Table 1 Demographic information for hospitalized cardiac patients.
From: Using smart speakers to contactlessly monitor heart rhythms
Regular rhythm (n = 18) | Irregular rhythm (n = 6) | |
|---|---|---|
Baseline characteristics, mean ± SD | ||
Age (years) | 63.2 ± 13.4 | 68.0 ± 7.6 |
Height (cm) | 172.5 ± 8.0 | 174.2 ± 14.0 |
Weight (kg) | 82.0 ± 17.6 | 74.0 ± 18.3 |
BMI (kg/m2) | 27.5 ± 5.0 | 24.3 ± 4.7 |
Female (n, %) | 2 (11.1%) | 2 (43.3%) |
Reason for admission, n (%) | ||
Acute coronary syndrome | 4 (22.2) | 0 (0.0) |
Heart failure exacerbation | 5 (27.8) | 4 (66.7) |
Cardiogenic shock | 4 (22.2) | 1 (16.7) |
Valve disease | 1 (5.6) | 1 (16.7) |
Other | 4 (22.2) | 0 (0.0) |
Comorbidities, n (%) | ||
Hypertension | 8 (44.4) | 3 (50.0) |
Hyperlipidemia | 6 (33.3) | 2 (33.3) |
Atrial fibrillation | 6 (33.3)a | 6 (100.0) |
Atrial flutter | 1 (5.6) | 0 (0.0) |
Conduction system disease | 3 (16.7) | 1 (16.7) |
Coronary artery disease | 6 (33.3) | 1 (16.7) |
Diabetes mellitus | 4 (22.2) | 1 (16.7) |
Congestive heart failure | 14 (77.8) | 5 (83.3) |
Valvular disease | 7 (38.9) | 4 (66.7) |
Heart transplant | 2 (11.1%) | 0 (0.0%) |
Stroke/transient ischemic attack | 4 (22.2) | 2 (33.3) |
Obstructive sleep apnea | 3 (16.7) | 2 (33.3) |
Chronic kidney disease | 6 (33.3) | 1 (16.7) |
Smoker | ||
Current | 2 (11.1) | 0 (0.0) |
Former | 3 (16.7) | 3 (50.0) |
Medications, n (%) | ||
ACE inhibitor | 4 (22.2) | 1 (16.7) |
Angiotensin receptor blocker | 3 (16.7) | 2 (33.3) |
Aldosterone antagonist | 5 (27.8) | 2 (33.3) |
Loop diuretic | 8 (44.4) | 3 (50.0) |
Beta blocker | 10 (56.6) | 2 (11.1) |
Calcium channel blocker | 1 (11.8) | 2 (28.6) |
Antiarrhythmic drug | 0 (0.0) | 0 (0.0) |
Statin | 12 (66.7) | 2 (33.3) |
Digoxin | 3 (16.7) | 0 (0.0) |
Oral anticoagulant | 7 (38.9) | 5 (83.3) |
Aspirin | 9 (50.0) | 3 (50.0) |
